133 related articles for article (PubMed ID: 32836195)
1. sIL-2R levels predict the spontaneous remission in sarcoidosis.
Zhou Y; Zhang Y; Zhao M; Li Q; Li H
Respir Med; 2020 Sep; 171():106115. PubMed ID: 32836195
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.
Grutters JC; Fellrath JM; Mulder L; Janssen R; van den Bosch JM; van Velzen-Blad H
Chest; 2003 Jul; 124(1):186-95. PubMed ID: 12853522
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.
Thi Hong Nguyen C; Kambe N; Kishimoto I; Ueda-Hayakawa I; Okamoto H
J Dermatol; 2017 Jul; 44(7):789-797. PubMed ID: 28295528
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of serum markers in pulmonary sarcoidosis.
Miyoshi S; Hamada H; Kadowaki T; Hamaguchi N; Ito R; Irifune K; Higaki J
Chest; 2010 Jun; 137(6):1391-7. PubMed ID: 20081103
[TBL] [Abstract][Full Text] [Related]
6. Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis.
Schimmelpennink MC; Quanjel M; Vorselaars A; Wiertz I; Veltkamp M; Van Moorsel C; Grutters JC
Expert Rev Respir Med; 2020 Jul; 14(7):749-756. PubMed ID: 32248706
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
Eurelings LEM; Miedema JR; Dalm VASH; van Daele PLA; van Hagen PM; van Laar JAM; Dik WA
PLoS One; 2019; 14(10):e0223897. PubMed ID: 31622413
[TBL] [Abstract][Full Text] [Related]
8. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
Vorselaars AD; van Moorsel CH; Zanen P; Ruven HJ; Claessen AM; van Velzen-Blad H; Grutters JC
Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
[TBL] [Abstract][Full Text] [Related]
9. Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy.
Chen W; Zhang Q; Li M; Huang G; Guo L; Chen Z; Ding Q; Gu Y
Clin Chim Acta; 2023 May; 545():117372. PubMed ID: 37127231
[TBL] [Abstract][Full Text] [Related]
10. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania.
Tsai SY; Yang YY; Kuo CJ; Chen CC; Leu SJ
J Affect Disord; 2001 May; 64(2-3):185-93. PubMed ID: 11313085
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug.
Kuuliala A; Leirisalo-Repo M; Möttönen T; Hannonen P; Nissilä M; Kautiainen H; Korpela M; Julkunen H; Hakola M; Repo H;
Clin Exp Rheumatol; 2005; 23(2):243-6. PubMed ID: 15895898
[TBL] [Abstract][Full Text] [Related]
12. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis.
Rothkrantz-Kos S; van Dieijen-Visser MP; Mulder PG; Drent M
Clin Chem; 2003 Sep; 49(9):1510-7. PubMed ID: 12928233
[TBL] [Abstract][Full Text] [Related]
13. [Serum soluble IL-2 receptor level in patients with sarcoidosis].
Ina Y; Takada K; Noda M; Satou T; Hashiba H; Miyachi A; Ito S; Iijima N; Yamamoto M
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152
[TBL] [Abstract][Full Text] [Related]
14. Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease.
Karim AF; Eurelings LEM; Bansie RD; van Hagen PM; van Laar JAM; Dik WA
Mediators Inflamm; 2018; 2018():6103064. PubMed ID: 29686532
[TBL] [Abstract][Full Text] [Related]
15. [Soluble interleukin 2 receptor (SIL-2R) in bronchoalveolar lavage fluid (BALF) of patients with sarcoidosis and atopic bronchial asthma].
Jankowska R; Passowicz-Muszyńska E; Gołecki M; Krasnowska M
Pneumonol Alergol Pol; 2002; 70(7-8):347-52. PubMed ID: 12708075
[TBL] [Abstract][Full Text] [Related]
16. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
[TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis.
Tsutsumi T; Nagai S; Imai K; Setoyama Y; Uchiyama T; Izumi T
Sarcoidosis; 1994 Sep; 11(2):102-9. PubMed ID: 7809492
[TBL] [Abstract][Full Text] [Related]
19. Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission.
Van Kemseke C; Belaiche J; Louis E
Int J Colorectal Dis; 2000 Aug; 15(4):206-10. PubMed ID: 11008719
[TBL] [Abstract][Full Text] [Related]
20. Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma: in combination with the International Prognostic Index.
Goto H; Tsurumi H; Takemura M; Ino-Shimomura Y; Kasahara S; Sawada M; Yamada T; Hara T; Fukuno K; Goto N; Okuno M; Takami T; Seishima M; Moriwaki H
J Cancer Res Clin Oncol; 2005 Feb; 131(2):73-9. PubMed ID: 15503137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
